Search results

5 items
  1. Martin Jelsma

    Profile
    Programme Director Drugs & Democracy

    Martin Jelsma is a political scientist who has specialised in Latin America and international drugs policy.  In 2005, he received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship, which stated that Jelsma "is increasingly recognized as one of, if not the, outstanding strategists in terms of how international institutions deal with drugs and drug policy."...

  2. Pien Metaal

    Profile
    Senior Project Officer

    Pien Metaal is a researcher with TNI. She holds a Master of Arts Degree in Political Science and International Relations from University of Amsterdam. She has been a member of the Transnational Institute's Drugs and Democracy team since 2002, though her participation with the Programme dates further back....

  3. Tom Blickman

    Profile
    Senior Project Officer

    Tom Blickman is a Senior Project Officer at the Transnational Institute (TNI), based in Amsterdam. Since 1997, he has been working for TNI's Drugs & Democracy Programme, specializing in international drug control policy and the UN conventions, drug markets, alternative development, money laundering and organised crime. Tom is a regular speaker at international policy conferences and advises...

  4. Ernestien Jensema

    Profile
    Project Coordinator Drug & Democracy

    Ernestien Jensema (1971) is a social anthropologist who has been working as a researcher and project coordinator with the Drugs & Democracy Programme of TNI since 2008. She focuses on issues related to the UN drug control system and the Drugs and Democracy Programme’s Asia project....

  5. publication

    The Dutch example shows that liberal drug laws can be beneficial

    • Craig Reinarman
    01 February 2000

    U.S. drug control officials have denounced Dutch drug policy as if it were the devil himself. One former U.S. Drug Czar said "you can't walk down the street in Amsterdam without tripping over junkies." In the Summer of 1998, however, one such denouncement turned into a small scandal. The first part of this chapter examines this incident as a window on the politics of drug policy. The second part offers a more general analysis of why U.S. drug control officials seem to be so threatened by the Dutch example.